Results 281 to 290 of about 682,890 (403)

OL-025 Research on the immunological mechanism of one new type adjuvant for therapeutic hepatitis B vaccine

, 2010
Peijiang He, X.C. Zhang, Zhongxiao Hu, Xin Fang, Shaohui Qiu, Zhihui Liang   +5 more
openalex   +1 more source

Correction: Islet autoantibodies in Thai individuals diagnosed with type 1 diabetes before 30 years of age: a large multicentre nationwide study. [PDF]

Diabetologia
Plengvidhya N, Suthon S, Nakdontri T, Teerawattanapong N, Ingnang S, Tangjittipokin W, Thai Type 1 Diabetes and Diabetes Diagnosed Before Age 30 Years Registry, Care, and Network (T1DDAR CN).   +8 more
europepmc   +1 more source

Targeting of HER2-Expressing Tumors Using 111In-ABY-025, a Second-Generation Affibody Molecule with a Fundamentally Reengineered Scaffold

Journal of Nuclear Medicine, 2010
S. Ahlgren, A. Orlova, H. Wållberg, M. Hansson, M. Sandström, R. Lewsley, A. Wennborg, L. Abrahmsén, V. Tolmachev, J. Feldwisch   +9 more
semanticscholar   +1 more source

Author Correction: Anopheles mosquito fauna, blood meal sources and transmission intensity from high and moderate malaria endemic areas of Ethiopia. [PDF]

Sci Rep
Woyessa D, Yewhalaw D.
europepmc   +1 more source

Cost Per Responder Analysis from the Checkmate 025 Phase III Trial of Nivolumab Versus Everolimus in Previously Treated Patients with Advanced Renal Cell Carcinoma [PDF]

, 2016
Liu Js, John C. Bell, R Sumati
openalex   +1 more source

The cyclophilin inhibitor Debio‐025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

Hepatology, 2008
R. Flisiak, A. Horban, P. Gallay, M. Bobardt, S. Selvarajah, A. Wiercińska-Drapało, E. Siwak, I. Cielniak, J. Higersberger, J. Kierkuś, C. Aeschlimann, P. Grosgurin, V. Nicolas-Metral, J. Dumont, H. Porchet, R. Crabbé, P. Scalfaro   +16 more
semanticscholar   +1 more source

Author Correction: Mechanism of skull base osteoradionecrosis explored through laboratory assessment with propensity score-matched analysis. [PDF]

Sci Rep
Li J, Hu X, Liang T, Zhang H, Yu C.
europepmc   +1 more source

S-025

, 2012
Jill Baumgartner, Yuanxun Zhang, James J. Schauer, Yuqin Wang, Majid Ezzati   +4 more
openalex   +1 more source

PD-025 RECOURSE trial: impact of adverse events on quality of life and duration of TAS-102 (trifluridine and tipiracil) treatment [PDF]

, 2016
Josep Tabernero, Jean-Paul Robert, Atsushi Ohtsu, Takayuki Yoshino, Rocio García‐Carbonero, Alessandro Pastorino, Marc Peeters, Robert Winkler, Lukas Makris, Mona Wahba, Alberto Zaniboni, Yoshifumi Shimada, Kentaro Yamazaki, Yoshito Komatsu, Howard S. Höchster, Heinz‐Josef Lenz, Alfredo Falcone, Bach Xuan Tran, Eric Van Cutsem   +18 more
openalex   +1 more source

Correction: Tolerating bad health research (part 2): still as many bad trials, but more good ones too. [PDF]

Trials
Daly A, Treweek S, Hayes GS, Shiely F.
europepmc   +1 more source